Axcan Pharma: Clinical Trials

5 completed. 5 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) VIOKASE 16 - Exocrine Pancreatic Insufficiency	Phase 2	Completed	Axcan Pharma	22	2008-03-01	2010-02-11
A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers. Itopride - Healthy Volunteers	Phase 2 / Phase 3	Completed	Mayo Clinic	45	2005-11-01	2011-03-23
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis Ursodesoxycholic acid - Serum Levels of ALAT Transaminases, Serum Markers for Fibrosis and Hepatic Inflammation	Phase 2	Completed	Axcan Pharma	98	2005-10-01	2009-02-03
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer Whole bladder laser light treatment as an alternative to radical cystectomy, Photofrin - Superficial Bladder Cancer	Phase 1 / Phase 2	Completed	North Florida/South Georgia Veterans Health System	22	2005-02-01	2012-10-26
Study of Combivir for Patients With Primary Biliary Cirrhosis Combination antiviral therapy, Placebo - Primary Biliary Cirrhosis	Phase 2 / Phase 3	Completed	University of Alberta	59	2004-01-01	2007-11-01